Volume 41, Issue 21 2000236
Communication

Visible Light—Responsive Drug Delivery Nanoparticle via Donor–Acceptor Stenhouse Adducts (DASA)

Jeaniffer E. Yap

Jeaniffer E. Yap

Cluster for Advanced Macromolecular Design (CAMD), School of Chemistry, University of New South Wales (UNSW), Sydney, NSW 2052 Australia

Search for more papers by this author
Lin Zhang

Lin Zhang

Cluster for Advanced Macromolecular Design (CAMD), School of Chemistry, University of New South Wales (UNSW), Sydney, NSW 2052 Australia

Search for more papers by this author
Jordan T. Lovegrove

Jordan T. Lovegrove

Cluster for Advanced Macromolecular Design (CAMD), School of Chemistry, University of New South Wales (UNSW), Sydney, NSW 2052 Australia

Search for more papers by this author
Jonathon E. Beves

Jonathon E. Beves

Cluster for Advanced Macromolecular Design (CAMD), School of Chemistry, University of New South Wales (UNSW), Sydney, NSW 2052 Australia

Search for more papers by this author
Martina H. Stenzel

Corresponding Author

Martina H. Stenzel

Cluster for Advanced Macromolecular Design (CAMD), School of Chemistry, University of New South Wales (UNSW), Sydney, NSW 2052 Australia

E-mail: [email protected]

Search for more papers by this author
First published: 09 August 2020
Citations: 35

Abstract

Stimuli-responsive drug release from a nanocarrier triggered by light enables the control of the amount of drug locally. Here, block copolymer micelles based on poly(ethylene glycol) methyl ether methacrylate (PEGMEMA) as the hydrophilic block and a polymer with pendant donor–acceptor Stenhouse adducts (DASA) are used as a means to trigger the release of drugs under green light. The micelles are loaded with ellipticine to yield light-responsive nanoparticles with sizes of around 35 nm according to transmission electron microscopy (TEM) analysis. Two micelles with a drug loading content of 4.75 and 7.4 wt% are prepared, but the micelle with the higher drug loading content leads to substantial protein adsorption. The release of ellipticine from the micelle, which is monitored using the polarity-sensitive fluorescence of ellipticine, can be switched on by light and off by thermal recovery of DASA in the dark. The micelles are readily taken up by Michigan Cancer Foundation-7 breast cancer cells. Subsequent light irradiation leads to enhanced drug release inside the cell as seen by the enhanced fluorescence.

Conflict of Interest

The authors declare no conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.